MICONAZOLE TREATMENT OF PITYRIASIS VERSICOLOR: A REVIEW.VAN CUTSEM J; REYNTJENS A.1978; MYKOSEN; DTSCH.; DA. 1978; VOL. 21; NO 3; PP. 87-91; ABS. ALLEM.; BIBL. 23 REF.Article

ANTIMYCOTIC IMIDAZOLES. V: SYNTHESIS AND ANTIMYCOTIC PROTERTIES OF 1-((2-ARYL-4-(ARYLALKYL)-1,3-DIOXOLAN-2-YL) METHYL)-H-IMIDAZOLESHEERES J; VAN CUTSEM J.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 11; PP. 1360-1364; BIBL. 18 REF.Article

Therapy of experimental meningeal and disseminated cryptococcosis = Die Therapie der experimentellen meningealen und disseminierten CryptococcoseVAN CUTSEM, J.Mycoses. 1993, Vol 36, Num 11-12, pp 357-367, issn 0933-7407Article

MICONAZOLE NITRATE IN THE TREATMENT OF DERMATOMYCOSESDEGREEF H; VERHOEVE L; VAN CUTSEM J et al.1975; DERMATOLOGICA; SUISSE; DA. 1975; VOL. 150; NO 2; PP. 103-110; BIBL. 1P.1/2Article

Animal models for dermatomycotic infectionsVAN CUTSEM, J.Current topics in medical mycology. 1989, Vol 3, pp 1-35, issn 0177-4204, 35 p.Article

ANTIMYCOTIC IMIDAZOLES. 3. SYNTHESIS AND ANTIMYCOTIC PROPERTIES OF 1-(2-(ARYLOXYALKYL)-2-PHENYLETHYL)-1H-IMIDAZOLES.HEERES J; BACKX LJJ; VAN CUTSEM J et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 11; PP. 1516-1520; BIBL. 4 REF.Article

THE ACTIVITY OF KETOCONAZOLE ON CLINICAL ISOLATES OF CANDIDA ALBICANS CULTURED IN A MYCELIUM PROMOTING MEDIUMVAN CUTSEM J; BORGERS M; DE BRABANDER M et al.1981; MYKOSEN; ISSN 0027-5557; DEU; DA. 1981; VOL. 24; NO 10; PP. 596-602; 5 P.; ABS. GER; BIBL. 15 REF.Article

ANTIMYCOTIC AZOLES. VI: SYNTHESIS AND ANTIFUNGAL PROPERTIES OF TERCONAZOLE, A NOVEL TRIAZOLE KETALHEERES J; HENDRICKX R; VAN CUTSEM J et al.1983; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1983; VOL. 26; NO 4; PP. 611-613; BIBL. 11 REF.Article

ANTIMYCOTIC IMIDAZOLES. 2. SYNTHESIS AND ANTIMYCOTIC PROPERTIES OF 1-(2-(ARYLALKYL)-2-PHENYLETHYL)-1H-IMIDAZOLES.HEERES J; MOSTMANS JH; VAN CUTSEM J et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 11; PP. 1511-1516; BIBL. 3 REF.Article

An investigation of the in vitro activity and antifungal spectrum of itraconazole and terbinafine in relation with in vivo efficacy in dermatophytosis and other mycosesVAN CUTSEM, J.Journal de mycologie médicale (Paris). 1994, Vol 4, Num 3, pp 137-144, issn 1156-5233Article

Prophylaxis of Candida and Aspergillus infections with oral administration of itraconazole = Prophylaxe von Candida- und Aspergillus-Infektionen durch orale Verabreichung von ItraconazolVAN CUTSEM, J.Mycoses. 1994, Vol 37, Num 7-8, pp 243-248, issn 0933-7407Article

Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animalsVAN CUTSEM, J.Mycoses. 1989, Vol 32, pp 14-34, issn 0933-7407, 21 p., suppl. 1Conference Paper

The in-vitro antifungal spectrum of itraconazoleVAN CUTSEM, J.Mycoses. 1989, Vol 32, pp 7-13, issn 0933-7407, 7 p., suppl. 1Conference Paper

TREATMENT OF GASTROINTESTINAL CANDIDOSIS IN PREDISPOSED GUINEA PIGS AND IN CONVENTIONAL MICE WITH MICONAZOLETHIENPONT D; VAN CUTSEM J; GOUGH DA et al.1978; MYKOSEN; DEU; DA. 1978; VOL. 21; NO 12; PP. 417-424; ABS. GER; BIBL. 11 REF.Article

A CONTROLLED TRIAL WITH MICONAZOLE (R14889) IN THE PREVENTION OF YEAST INFECTIONS OCCURRING AFTER TREATMENT OF VAGINAL TRICHOMONIASIS = ESSAI CONTROLE AVEC LE MICONAZOLE (R14889) DANS LA PREVENTION DES INFECTIONS DE LEVURE SE PRODUISANT APRES TRAITEMENT DE LA VAGINITE A TRICHOMONASPEETERS F; SNAUWAERT R; VAN CUTSEM J et al.1974; EUROP. J. OBSTETR. GYNECOL.; NETHERL.; DA. 1974; VOL. 4; NO 3; PP. 95-99; BIBL. 13REF.Article

Primary cutaneous cryptococcosisBAES, H; VAN CUTSEM, J.Dermatologica. 1985, Vol 171, Num 5, pp 357-361, issn 0011-9075Article

ANTIMYCOTIC IMIDAZOLES. IV: SYNTHESIS AND ANTIFUNGAL ACTIVITY OF KETOCONAZOLE, A NEW POTENT ORALLY ACTIVE BROAD-SPECTRUM ANTIFUNGAL AGENTHEERES J; BACKX LJJ; MOSTMANS JH et al.1979; J. MEDICIN. CHEM.; USA; DA. 1979; VOL. 22; NO 8; PP. 1003-1005; BIBL. 13 REF.Article

Fungal infections in birds in captivity - sic case reportsVAN CUTSEM, J; FRANSEN, J.Mykosen. 1987, Vol 30, Num 4, pp 166-171, issn 0027-5557Article

THE BIOLOGICAL AND TOXICOLOGICAL PROPERTIES OF IMAZALILTHIENPONT D; VAN CUTSEM J; VAN CAUTEREN H et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 2; PP. 309-315; ABS. GER; BIBL. 8 REF.Article

VAPOUR PHASE ACTIVITY OF IMAZALILVAN GESTEL J; VAN CUTSEM J; THIENPONT D et al.1981; CHEMOTHERAPY (BASEL); ISSN 0009-3157; CHE; DA. 1981; VOL. 27; NO 4; PP. 270-276; BIBL. 17 REF.Article

LES INFECTIONS EXPERIMENTALES A CANDIDA ALBICANS DU TRACTUS DIGESTIF ET LEUR TRAITEMENT PAR LE KETOCONAZOLEVAN CUTSEM J; VAN GERVEN F; VAN DER FLAES M et al.1982; BULL. SOC. FR. MYCOL. MED.; ISSN 0373-8744; FRA; DA. 1982; VOL. 11; NO 1; PP. 105-111; ABS. ENG; BIBL. 11 REF.Article

SYSTEMIC ANTIFUNGAL POTENTIAL, SAFETY, BIOTRANSPORT AND TRANSFORMATION OF MICRONAZOLE NITRATE = EFFICACITE ANTIFONGIQUE PAR VOIE GENERALE, INNOCUITE, TRANSPORT BIOLOGIQUE ET TRANSFORMATION DU NITRATE DE MICONAZOLEBRUGMANS J; VAN CUTSEM J; HEYKANTS J et al.1972; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1972; VOL. 5; NO 2; PP. 93-99; BIBL. 11 REF.Serial Issue

THE ACTIVITY OF KETOCONAZOLE IN MIXED CULTURES OF LEUKOCYTES AND CANDIDA ALBICANSDE BRABANDER M; AERTS F; VAN CUTSEM J et al.1980; SABOURAUDIA; ISSN 0036-2174; GBR; DA. 1980; VOL. 18; NO 3; PP. 197-210; ABS. FRE; BIBL. 16 REF.Article

THE INFLUENCE OF GASTRIC ACIDITY ON THE BIO-AVAILABILITY OF KETOCONAZOLEVAN DER MEER JWM; KEUNING JJ; SCHEIJGROND HW et al.1980; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1980; VOL. 6; NO 4; PP. 552-554; BIBL. 11 REF.Article

In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agentsVAN CUTSEM, J.Chemotherapy (Basel). 1992, Vol 38, pp 3-11, issn 0009-3157, SUP1Conference Paper